United Kingdom · Question · Written question
UIN 62442
Alzheimer's Disease: Donanemab and Lecanemab
Introduced
24 June 2025
Last action
—
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
1 July 2025
Summary
To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on its decision not to recommend the use of donanemab and lecanemab for Alzheimer's patients by the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.